← Back to headlines
Needham Adjusts Price Targets for Revolution and Global-E Online
Wall Street firm Needham has revised equity outlooks for multiple healthcare and fintech companies, raising targets for Revolution on drug approval catalysts while reaffirming a buy rating for Global-E Online with a $47 price target.
1 Sept, 10:56 — 1 Sept, 10:56
Sources
Showing 1 of 1 sources
